Loading...
Loading...
TURKCELL ILETISIM HIZMETLERI A S
TURKCELL ILETISIM HIZMETLERI A S. Spoken Alpha tracks TKC's earnings calls, guidance changes, and executive accountability over time.
Spoken Alpha tracks TKC's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Misses consensus 10/10 quarters
SampleRepeated misses without a guidance reset suggest management is structurally optimistic relative to operating reality. Track whether next-quarter guidance is being benchmarked off the prior miss or the prior plan.
Missed in 4 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for TKC.
curl https://api.spokenalpha.com/v1/companies/TKC| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $3.71 | $4.34 | -14.6% | -5.8% | -6.2% |
| Q4 FY2026 | $3.64 | $4.37 | -16.6% | -0.1% | 0.0% |
| Q3 FY2026 | $3.57 | $4.38 | -18.5% | -2.3% | -4.7% |
| Q2 FY2026 | $3.98 | $4.45 | -10.5% | -6.6% | -7.9% |
| Q1 FY2025 | $3.67 | $4.50 | -18.5% | -3.2% | -2.0% |
| Q4 FY2025 | $3.54 | $4.43 | -20.1% | +0.8% | +2.0% |
| Q3 FY2025 | $3.85 | $4.68 | -17.8% | -4.7% | -4.9% |
| Q2 FY2025 | $4.16 | $4.54 | -8.4% | -3.8% | -1.0% |
| Q1 FY2024 | $4.20 | $4.74 | -11.4% | +4.5% | +6.7% |
| Q4 FY2024 | $3.87 | $4.64 | -16.6% | +4.3% | +5.6% |